Sex differences in long-term outcomes of patients across the spectrum of coronary artery disease - 12/12/18
, Daniel W. Mudrick, MD, MPH b, Karen Chiswell, PhD a, Amanda Brucker, MS a, c, Eric D. Peterson, MD, MPH a, Pamela S. Douglas, MD aAbstract |
Background |
Patients with nonobstructive coronary artery disease (CAD) have worse outcomes compared with those without CAD; however, few studies have compared the intermediate- and long-term impact of CAD severity as a function of patient sex.
Methods |
We evaluated 5-year and long-term all-cause mortality of women and men undergoing elective coronary angiography at a single center by degree of CAD: no CAD (1%-24% stenosis), nonobstructive CAD (25%-69% epicardial stenosis or 25%-49% left main stenosis), or obstructive CAD (epicardial stenosis ≥70% or left main stenosis ≥50%), both overall and after adjusting for baseline clinical risk factors using Cox proportional-hazards models.
Results |
Between January 1986 and July 2010, 8,766 women and 11,638 men underwent angiography and were followed for a median of 9.2 years. The majority (67%) of women had no CAD or nonobstructive CAD, whereas the majority of men had obstructive CAD (56%, P < .001). In both sexes, increasing CAD was associated with increased 5-year risk of mortality. Risk-adjusted hazard ratios (vs no CAD) for women were 1.36 (95% CI, 1.16-1.60) and 1.86 (1.61-2.16) for nonobstructive and obstructive CAD, respectively; corresponding hazard ratios for men were 1.24 (1.06-1.45) and 1.38 (1.20-1.59). After risk adjustment, 5-year mortality risk was higher in men than in women at all levels of CAD severity. The relationships between severity of CAD and mortality risk during long-term follow-up in women and men were similar to the 5-year relationships above.
Conclusions |
Although women undergoing elective catheterization have less severe CAD than men, nonobstructive CAD is prevalent in both sexes and carries a worse prognosis than no CAD. These data suggest a need for further investigation to establish optimal therapies for this at-risk group of patients with nonobstructive CAD.
Le texte complet de cet article est disponible en PDF.Plan
| Jeffrey S. Berger, MD, MS, served as guest editor for this article. |
Vol 206
P. 51-60 - décembre 2018 Retour au numéro
Article précédent
- Thirty-day outcomes in patients with acute pulmonary embolism who discontinued anticoagulant therapy before 90 days
- José A. Nieto, Julio A. Vicente, Luis M. Prieto, David Jiménez, Behnood Bikdeli, Agustina Rivas, José Antonio Porras, Mª del Valle Morales, Marijan Bosevski, Manuel Monreal, RIETE Investigators 1
- The East–West late lumen loss study: Comparison of angiographic late lumen loss between Eastern and Western drug-eluting stent study cohorts
- Robert W. Harrison, Vaishnavi Radhakrishnan, John C. Allen, Peter S. Lam, Dominic J. Allocco, Sandeep Brar, Martin Fahy, Zhen Zhang, Rebecca Fisher, Fumiaki Ikeno, Philippe Généreux, Takeshi Kimura, Minglei Liu, Weng Kit Lye, Hirofumi Nagai, Yuka Suzuki, Roseann White, Mitchell W. Krucoff
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?